Tenax Therapeutics, Inc. (TENX)
1.52
+0.16
(+11.76%)
USD |
NASDAQ |
Oct 19, 15:33
Tenax Therapeutics Cash from Operations (Annual) : -35.80M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -35.80M |
| December 31, 2024 | -14.81M |
| December 31, 2023 | -5.904M |
| December 31, 2022 | -12.01M |
| December 31, 2021 | -10.86M |
| December 31, 2020 | -9.273M |
| December 31, 2019 | -7.556M |
| December 31, 2018 | -5.500M |
| December 31, 2017 | -12.14M |
| December 31, 2016 | -15.87M |
| April 30, 2016 | |
| April 30, 2015 | -9.749M |
| April 30, 2014 | -9.262M |
| Date | Value |
|---|---|
| April 30, 2013 | -4.921M |
| April 30, 2012 | -8.278M |
| April 30, 2011 | -8.403M |
| April 30, 2010 | -8.587M |
| April 30, 2009 | -4.058M |
| April 30, 2008 | -2.276M |
| April 30, 2007 | -1.138M |
| April 30, 2006 | -2.148M |
| April 30, 2005 | -1.992M |
| April 30, 2004 | -1.774M |
| April 30, 2003 | -2.094M |
| April 30, 2002 | -1.898M |
| April 30, 2001 | -1.538M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | -8.555M |
| Century Therapeutics, Inc. | -103.88M |
| Absci Corp. | -92.92M |
| Celularity, Inc. | -13.25M |